Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Hypertension

Explore clinical trials studying Pulmonary Hypertension. Study availability and eligibility vary by location and protocol.

453 public trials 93 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Hypertension trial results

Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT06388421

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner Health - University Medical Center Phoenix Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado - Anschutz Medical Campus Aurora, Colorado, United States
View all 71 locations
View Trial Details
Recruiting

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

NCT07214376

Conditions
Cardiovascular Diseases, Heart Diseases, Heart Failure, +9 more
Locations
  • Cardiovascular Institute of the South Houma, Louisiana, United States
  • Oklahoma Heart Institute Tulsa, Oklahoma, United States
  • University of Pittsburgh Medical Center Mechanicsburg, Pennsylvania, United States
  • Banner - University Medical Center Tucson Tucson, Arizona, United States
View Trial Details
Recruiting

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT07179380

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +6 more
Locations
  • USA010 Los Angeles, California, United States
  • USA001 Santa Barbara, California, United States
  • USA006 Naples, Florida, United States
  • USA026 St. Petersburg, Florida, United States
View all 145 locations
View Trial Details
Recruiting

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT07234032

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +6 more
Locations
  • USA006 Naples, Florida, United States
  • USA003 Bend, Oregon, United States
  • JPN004 Narita, Chiba, Japan
  • KOR001 Seoul, South Korea
View Trial Details

Related conditions